Yahoo! Finance: VVUS News

Correction: Obesity drugs story (AP)

Wed, 23 Dec 2009 20:14:25 Etc/GMT

In a Dec. 22 story about obesity drugs, The Associated Press erroneously reported the date Vivus Inc. plans to file for approval of its drug candidate Qnexa. Vivus says it will file for approval by the end of 2009, not early 2010.

[video] Top 2010 Stocks Under $10 (at TheStreet.com)

Tue, 22 Dec 2009 20:00:00 Etc/GMT

[video] Top Stocks Under $10 for 2010 (at TheStreet.com)

Tue, 22 Dec 2009 20:00:00 Etc/GMT

UPDATE - Arena files for approval for weight loss drug (at Reuters)

Tue, 22 Dec 2009 18:38:34 Etc/GMT

Arena files for FDA approval of obesity drug (AP)

Tue, 22 Dec 2009 16:01:42 Etc/GMT

The first of a new class of obesity drugs moved one step closer to the market Tuesday, as Arena Pharmaceuticals Inc. said it filed for approval of its drug candidate lorcaserin.

Arena shares fall on Jefferies coverage, caution (AP)

Thu, 17 Dec 2009 17:42:02 Etc/GMT

Shares of Arena Pharmaceuticals Inc. fell Thursday after a Jefferies & Co. analyst started coverage on the drug developer with an upbeat but cautious view on the obesity drug candidate lorcaserin.

[$$] Deal Talk Drives Rockwell Action (at The Wall Street Journal Online)

Wed, 16 Dec 2009 01:29:28 Etc/GMT

StockPreacher Initiates Independent Research Coverage for Vivus Inc. (GlobeNewswire)

Tue, 15 Dec 2009 11:50:00 Etc/GMT

DALLAS -- StockPreacher.com announces an investment report featuring drug manufacturing company Vivus Inc. . The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.

Biotech Calendar: Key Dates for December (at TheStreet.com)

Mon, 30 Nov 2009 14:56:24 Etc/GMT

A Big Upgrade for Amylin Pharmaceuticals (at Motley Fool)

Wed, 25 Nov 2009 20:20:32 Etc/GMT

VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)

Tue, 24 Nov 2009 21:12:19 Etc/GMT

3 Stocks Ready to Roar (at Motley Fool)

Tue, 24 Nov 2009 19:00:07 Etc/GMT

The Side Effect of Developing Obesity Drugs (at Motley Fool)

Mon, 23 Nov 2009 21:13:28 Etc/GMT

Poniard Finds Cash to Keep Lights On: BioBuzz (at TheStreet.com)

Mon, 23 Nov 2009 17:59:22 Etc/GMT

Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzz (at TheStreet.com)

Mon, 23 Nov 2009 15:14:59 Etc/GMT

FDA Issues New Obesity Drug Heart Warning: BioBuzz (at TheStreet.com)

Mon, 23 Nov 2009 13:15:28 Etc/GMT

Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst (Wall Street Transcript)

Fri, 20 Nov 2009 14:49:00 Etc/GMT

67 WALL STREET, New York - November 20, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 76 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available via The Wall Street Transcript Online.

Trading Review for Vivus Inc. Issued by Beacon Equity (GlobeNewswire)

Fri, 20 Nov 2009 11:50:00 Etc/GMT

DALLAS -- BeaconEquity.com announces an investment report featuring biopharmaceutical company Vivus Inc. . The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

Biotech Stock Mailbag: FDA Playbook (at TheStreet.com)

Fri, 20 Nov 2009 11:01:45 Etc/GMT

CTT's Pain Mangement Device Sales to Result in Positive Surprise in 10Q (at Seeking Alpha)

Thu, 19 Nov 2009 16:37:21 Etc/GMT